Koers Maravai LifeSciences Holdings, Inc.
Aandelen
MRVI
US56600D1072
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,58 USD | +2,88% | +4,76% | +30,99% |
Omzet 2024 * | 273 mln. 253 mln. | Omzet 2025 * | 301 mln. 279 mln. | Marktkapitalisatie | 1,14 mld. 1,05 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,56 mln. | Nettowinst (verlies) 2025 * | 4 mln. 3,71 mln. | EV/omzet 2024 * | 4,14 x |
Nettoliquiditeiten 2024 * | 7,67 mln. 7,11 mln. | Nettoliquiditeiten 2025 * | 83,36 mln. 77,25 mln. | EV/omzet 2025 * | 3,49 x |
K/w-verhouding 2024 * |
-194
x | K/w-verhouding 2025 * |
668
x | Werknemers | 650 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 43,65% |
Recentste transcriptie over Maravai LifeSciences Holdings, Inc.
1 dag | +2,88% | ||
1 week | +4,76% | ||
Lopende maand | +11,00% | ||
1 maand | +3,87% | ||
3 maanden | +28,83% | ||
6 maanden | -12,09% | ||
Lopend jaar | +30,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Martin
CEO | Chief Executive Officer | 49 | 30-09-22 |
Carl Hull
FOU | Founder | 66 | 01-03-14 |
Kevin Herde
DFI | Director of Finance/CFO | 53 | 01-05-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | 01-03-16 |
Sean Cunningham
BRD | Director/Board Member | 48 | 01-03-16 |
Gregory Lucier
BRD | Director/Board Member | 60 | 01-01-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.50% | 12 M€ | -.--% | - | |
0.37% | 8 M€ | +6,91% | ||
0.34% | 2 M€ | +12,97% | ||
0.28% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 8,58 | +2,88% | 1 855 942 |
26-03-24 | 8,34 | -1,77% | 1 801 098 |
25-03-24 | 8,49 | -3,08% | 2 080 405 |
22-03-24 | 8,76 | +7,35% | 3 569 837 |
21-03-24 | 8,16 | -0,37% | 5 755 687 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,99% | 1,14 mld. | |
-9,60% | 12,14 mld. | |
+73,43% | 3,94 mld. | |
-33,60% | 2,19 mld. | |
-21,05% | 1,63 mld. | |
+9,17% | 852 mln. | |
-12,33% | 545 mln. | |
-41,02% | 419 mln. | |
+28,48% | 249 mln. | |
+4,73% | 234 mln. |